195 related articles for article (PubMed ID: 17998872)
1. Induction of indefinite cardiac allograft survival correlates with toll-like receptor 2 and 4 downregulation after serine protease inhibitor-1 (Serp-1) treatment.
Jiang J; Arp J; Kubelik D; Zassoko R; Liu W; Wise Y; Macaulay C; Garcia B; McFadden G; Lucas AR; Wang H
Transplantation; 2007 Nov; 84(9):1158-67. PubMed ID: 17998872
[TBL] [Abstract][Full Text] [Related]
2. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
Ulusal BG; Ulusal AE; Hung LM; Wei FC
J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843
[TBL] [Abstract][Full Text] [Related]
3. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
[TBL] [Abstract][Full Text] [Related]
4. Viral serine proteinase inhibitor (SERP-1) effectively decreases the incidence of graft vasculopathy in heterotopic heart allografts.
Hausen B; Boeke K; Berry GJ; Morris RE
Transplantation; 2001 Aug; 72(3):364-8. PubMed ID: 11502962
[TBL] [Abstract][Full Text] [Related]
5. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
6. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
Mark W; Schneeberger S; Seiler R; Stroka DM; Amberger A; Offner F; Candinas D; Margreiter R
Transplantation; 2003 Apr; 75(7):940-5. PubMed ID: 12698077
[TBL] [Abstract][Full Text] [Related]
7. Prevention of chronic renal allograft rejection by SERP-1 protein.
Bédard EL; Jiang J; Arp J; Qian H; Wang H; Guan H; Liu L; Parry N; Kim P; Garcia B; Li X; Macaulay C; McFadden G; Lucas A; Zhong R
Transplantation; 2006 Mar; 81(6):908-14. PubMed ID: 16570016
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
[TBL] [Abstract][Full Text] [Related]
10. The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model.
Shiraishi M; Csete M; Yasunaga C; McDiarmid SV; Vannice JL; Busuttil RW; Shaked A
J Surg Res; 1995 May; 58(5):465-70. PubMed ID: 7745957
[TBL] [Abstract][Full Text] [Related]
11. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
[TBL] [Abstract][Full Text] [Related]
13. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
14. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
Lijkwan MA; Cooke DT; Martens JM; Kown MH; Murata S; Peterson SH; Hoyt EG; Robbins RC
J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cardiac allograft survival by Vav1-Rac signaling blockade in a mouse model.
Wang S; Diao H; Guan Q; Jevnikar AM; Du C
Transpl Immunol; 2007 Jul; 18(1):53-61. PubMed ID: 17584603
[TBL] [Abstract][Full Text] [Related]
17. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
[TBL] [Abstract][Full Text] [Related]
18. Poly (ADP) ribose polymerase inhibition improves rat cardiac allograft survival.
Farivar AS; McCourtie AS; MacKinnon-Patterson BC; Woolley SM; Barnes AD; Chen M; Jagtap P; Szabó C; Salerno CT; Mulligan MS
Ann Thorac Surg; 2005 Sep; 80(3):950-6. PubMed ID: 16122462
[TBL] [Abstract][Full Text] [Related]
19. Cardiac allograft rejection correlates with increased expressions of Toll-like receptors 2 and 4 and allograft inflammatory factor 1.
McDaniel DO; Zhou X; Moore CK; Aru G
Transplant Proc; 2010 Dec; 42(10):4235-7. PubMed ID: 21168672
[TBL] [Abstract][Full Text] [Related]
20. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
